Finding new nucleants
to promote protein crystallization is an
important task, especially for purposes other than structural determination.
Here, we investigated cyclodextrins and its derivative particles,
as potential nucleants for protein crystallization. β-Cyclodextrin
(β-CD) and its derivatives (including p-toluenesulfonyl-β-cyclodextrin
(PTCD), polymer-β-cyclodextrin (PCD), mono-(6-(1,6-hexamethylenediamine)-6-deoxy)-β-cyclodextrin
(MHCD) and mercapto-β-cyclodextrin (MCD)) were used as nucleants.
The experimental results confirmed that β-CD and its derivatives
showed significantly positive effects, promoting protein crystallization
and improving crystal quality. A larger number of protein molecules
(including lysozyme, catalase, subtilisin A VIII, concanavalin A VI,
α-chymotrypsinogen, proteinase K, cellulase, papain, glucose
isomerase, hemoglobin, and ribonuclease A XII) attached to the particles
usually corresponded to a higher crystallization success rate. More
detailed analysis showed that cyclodextrins exhibited the best performance
when the overall charge of protein in solution was the opposite to
zeta potential of the cyclodextrins particle. Our results showed that
cyclodextrins can be useful as nucleants due to the ease of modifying
them to suit the crystallization of different proteins, and they can
be explored for use in the mass purification of proteins for the biopharmaceutical
industry. Furthermore, the phenomenon discovered in this study pointed
toward a way to find new nucleants based on the overall charge of
proteins in a solution: the nucleants should preferably be the opposite
between the overall charge of target protein and the zeta potential
of the cyclodextrin particle.